2 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Dengue Fever: new trials by email Literature Review of Dengue Fever trials Research Report on Dengue Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IC14 in Adult Patients With Dengue Fever IC14, Placebo - Dengue Fever | Phase 2 | Withdrawn | Implicit Bioscience | 2019-05-01 | 2026-05-05 | |
| Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore Celgosivir, Modipafant 50mg, Placebo - Dengue Fever | Phase 1 / Phase 2 | Withdrawn | Singapore General Hospital | 2018-12-01 | 2020-03-23 |
Dengue (2)
Arbovirus Infections (2) · Flaviviridae Infections (2) · Flavivirus Infections (2) · Hemorrhagic Fevers, Viral (2) · Infections (2) · Mosquito-Borne Diseases (2) · RNA Virus Infections (2) · Vector Borne Diseases (2) · Virus Diseases (2)
celgosivir (1) · modipafant (1)
Implicit Bioscience (1) · Singapore General Hospital (1)
Singapore (1)
Jan Agosti, MD (1) · Jenny Low, Dr (1)